Can-Fite BioPharma (CANF) Prices 3.9M ADS Registered Offering at $2.05/ADS

Go back to Can-Fite BioPharma (CANF) Prices 3.9M ADS Registered Offering at $2.05/ADS

Can-Fite BioPharma (CANF) Announces, Following Pre-IND Guidance from FDA, to Advance Piclidenoson into Phase II COVID-19 Trial in the U.S.

June 9, 2020 7:02 AM EDT

Can-Fite BioPharma Ltd. (NYSE: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary... More